The largest database of trusted experimental protocols

327 protocols using prism software 5

1

Quantifying Protein-Peptide Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
For direct FP binding assays, FlTC-derivatized BIM BH3 peptides (50 nM) were added to serial dilutions of recombinant protein in binding buffer (BCL-XL ΔC: 100 mM NaCl, 50 mM Tris, pH 8.0; full-length BAX and BCL-XL: 140 mM NaCl, 50 mM Tris, pH 7.4) in 96-well black opaque plates. For binding assays employing BAX A112C/V177C, the protein stock and binding buffer was supplemented with GSSG (0.5 mM). The plates were incubated in the dark at RT and then fluorescence polarization measured at 20 min on a microplate reader (SpectraMax M5 Microplate Reader, Molecular Devices). Dissociation constants (KD) were calculated by nonlinear regression analysis of dose-response curves with Prism software 5.0 (GraphPad) using the ligand depletion formula for FP binding assays, as described.13 (link),35 For competitive FP binding assays, FITC-derivatized BID BH3 peptide (25 nM) composed of the sequence DIIRNIARHLAQVGDSBDRSI (where B is norleucine) was added to BCL-XL ΔC protein (250 nM) and serial dilutions (starting from 1 μm) of Ac-BIM BH31 or Ac-BIM SAHBA1 in 96-well black opaque plates. The plates were incubated in the dark at RT and then FP measured at 20 min as above. IC50s were calculated by nonlinear regression analysis of dose-response curves using Prism software 5.0 (GraphPad) and Kis calculated according to the formula, Ki = IC50/(1 + [L/KD]).
+ Open protocol
+ Expand
2

Statistical Analysis Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Student's t test, chi-square test, and unpaired t test were performed with GraphPad Prism software 5.0 (GraphPad Software, San Diego, CA) to compare various test groups. Kaplan–Meier survival analysis was also performed with GraphPad Prism software 5.0 (GraphPad Software).
+ Open protocol
+ Expand
3

Evaluating Cell Viability and Phytochemical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the percentages of cell survivability were expressed as mean (n = 3) per plate ± SD (Standard deviation) and differences among treated and untreated cells were analysed using one way ANOVA followed Dunnett’s multiple comparison test. The test was considered statistically significant when P < 0.05 as compared to untreated cell (control) and GraphPad Prism Software 5.0 was used to analyse all statistical tests.
Data were expressed as mean of three times experiment (n = 3) ± SD (standard deviation) and the difference of TPC and TFC among sample extracts were determined using one way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. The statistical analysis test was performed using GraphPad Prism Software 5.0. The sample was differred significantly when (P < 0.05).
+ Open protocol
+ Expand
4

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using analysis of variance (ANOVA) followed by the Newman–Keuls test. The analyses were performed using PRISM software 5.0 (Graph Pad Software), and all data are presented as the means ± SEMs; p-values < 0.05 were accepted as statistically significant.
+ Open protocol
+ Expand
5

Cell Viability Assay for B-ALL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B-ALL cells (4×104/well) were seeded in 96-well opaque plates in a volume of 40 μL in serum-free RPMI using a multiwell dispenser (Apricot) to ensure consistency and reproducibility among the 5–7 plates required per panel. A 2× concentrated plate of the indicated serial dilutions of peptide (10 mM DMSO stock) or DMSO (0.4%) in serum-free RPMI in a volume of 40 μL was then transferred to the cells and the plate incubated at 37°C for 4 hours, at which time, 8.9 μL per well of 100% FBS was added back and cell viability assayed 20 h later by addition of CellTiter-Glo reagent, according to the manufacturer’s protocol (Promega). IC50s were calculated by nonlinear regression analysis of dose-response curves using Prism software 5.0 (GraphPad).
+ Open protocol
+ Expand
6

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro and cell studies were done at least in quadruplicate. Statistical analyses of western blot bands and catechol contents were analyzed by one-way analyses of variance using GraphPad Prism Software 5.0. A p value less than 0.05 defined statistical significance.
+ Open protocol
+ Expand
7

Fluorescent Peptide Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For direct FP binding assays, FlTC-derivatized peptides (25 nM) were added to serial dilutions of recombinant protein in binding buffer (100 mM NaCl, 50 mM Tris, pH 8.0) in 96-well black opaque plates. The plates were incubated in the dark at RT and then fluorescence polarization measured at 20 min on a microplate reader (SpectraMx M5 Microplate Reader, Molecular Devices). EC50s were calculated by nonlinear regression analysis of dose−response curves using Prism software 5.0 (GraphPad).
+ Open protocol
+ Expand
8

Chromosomal Aberrations and Cancer Prognosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Association of the chromosomal aberrations with metastasis, disease stage, tumor size or survival was analyzed using Fisher's exact test, Kaplan–Meier survival analysis and the log rank test (GraphPad Prism Software 5.0, San Diego, CA). Statistical tests were two sided with default significance level of 0.05. Univariate logistic regression and univariate Cox regression were performed using R statistical software v3.2.0 as described previously [59 (link)].
+ Open protocol
+ Expand
9

Predictive Modeling of Intramuscular Fat

Check if the same lab product or an alternative is used in the 5 most similar protocols
GraphPad Prism software 5.0 (GraphPad, Santiago, CA, USA) was used to assess all data. One-way analysis of variance (ANOVA) and two-tail Student’s t-test were used in this study. A general linear model was fitted in the R software environment [27 ] to develop prediction models for APMAP expression level and IMF. The model is as follows, Intramuscular fat = APMAP expression level + Age. Marginal and conditional R2 values were calculated for the model. p < 0.05 and p < 0.01 were significant and highly significant, respectively.
+ Open protocol
+ Expand
10

Cytotoxicity Assay with Selective BRAF Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dabrafenib, vemurafenib, and YK-4-279 were purchased from Selleck Chemicals (Houston, TX, USA). Low densities of cells ranging from 0.5 × 103-3 × 103 cells/well depending on the respective cell proliferation time were seeded in 500 μl growth media in duplicates in 24-well plates and settled for 24 h under normal cell culture conditions. Upon the recovery time, the indicated drug concentration was added in 100 μl growth medium. Following drug exposure time of 7 days, cells were washed with phosphate-buffered saline (PBS) and fixed with ice-cold methanol for 30 min at 4 °C before cells were stained using crystal violet. Digital photographs were taken using a Nikon D3200 camera and processed with ImageJ software. For quantification, crystal violet was eluted using 2% sodium dodecyl sulfate and color absorbance was measured at 560 nm at the Tecan infinite 200Pro (Zurich, Switzerland). Values were analyzed using GraphPad Prism software 5.0 and are given in arbitrary units (AU) as mean +/− standard deviation (SD) normalized to untreated control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!